Linda Liau

Last updated

Linda M. Liau is an American neurosurgeon, neuroscientist, and the W. Eugene Stern Chair of the Department of Neurosurgery at the David Geffen School of Medicine at UCLA. Liau was elected to the Society of Neurological Surgeons in 2013 and the National Academy of Medicine in 2018. She has published over 230 research articles and a textbook, Brain Tumor Immunotherapy. She served as editor-in-chief of the Journal of Neuro-Oncology from 2007 to 2017. [1]

Contents

Early life and education

Liau was raised in Los Angeles, California. [2] She received bachelor's degrees in biochemistry and political science from Brown University in 1987 and completed medical school at Stanford University in 1991. She also obtained a PhD in neuroscience in 1999 at UCLA, where she completed her residency and training in neurosurgery. [1] She was inspired to pursue a career in neurosurgery after her mother died from breast cancer that had metastasized to her brain when Liau was in her third year of residency. [3]

Career and research

Liau is currently the chair of the Department of Neurosurgery at the David Geffen School of Medicine at UCLA, making her the second woman in the United States, and the first Asian-American woman, to chair an academic neurosurgical department. [4]

Liau's primary research interest is the treatment of glioblastoma, a deadly form of brain cancer. [4] Apart from surgical treatment, she has also worked on immunotherapy, [1] [4] and in the 1990s created one of the first personalized vaccines against brain cancer by using a sample of a patient's own tumor and white blood cells to activate an immune response against the cancer. [4] She has since pioneered the use of dendritic cell-based vaccines in the treatment of glioblastoma. Other research she has performed includes the development of new techniques to map brain function during brain surgeries while the patient is awake. [1]

Personal life

Liau is married to Marvin Bergsneider, also a neurosurgeon at UCLA, with whom she has two children. [3]

Related Research Articles

<span class="mw-page-title-main">Neurosurgery</span> Medical specialty of disorders which affect any portion of the nervous system

Neurosurgery or neurological surgery, known in common parlance as brain surgery, is the medical specialty concerned with the surgical treatment of disorders which affect any portion of the nervous system including the brain, spinal cord and peripheral nervous system.

<span class="mw-page-title-main">Brain tumor</span> Neoplasm in the brain

A brain tumor occurs when abnormal cells form within the brain. There are two main types of tumors: malignant tumors and benign (non-cancerous) tumors. These can be further classified as primary tumors, which start within the brain, and secondary tumors, which most commonly have spread from tumors located outside the brain, known as brain metastasis tumors. All types of brain tumors may produce symptoms that vary depending on the size of the tumor and the part of the brain that is involved. Where symptoms exist, they may include headaches, seizures, problems with vision, vomiting and mental changes. Other symptoms may include difficulty walking, speaking, with sensations, or unconsciousness.

<span class="mw-page-title-main">Alfredo Quiñones-Hinojosa</span> American physician

Alfredo Quiñones-Hinojosa is a Mexican-American neurosurgeon, author, and researcher. Currently, he is the William J. and Charles H. Mayo Professor and Chair of Neurologic Surgery and runs a basic science research lab at the Mayo Clinic Jacksonville in Florida.

<span class="mw-page-title-main">Gail Rosseau</span>

Gail Linskey Rosseau is Clinical Professor of Neurosurgery at George Washington University School of Medicine and Health Sciences, Washington, D.C. Prior to this position, she was Associate Chairman of Inova Fairfax Hospital Department of Neurosciences. She previously served as director of skull base surgery of NorthShore University HealthSystem. She is board-certified and has been an examiner for the American Board of Neurological Surgery. She has been elected to the leadership of the American Association of Neurological Surgeons, World Federation of Neurosurgical Societies, and the Société de Neurochirurgie de Langue Française.

Griffith Rutherford Harsh IV is an American neurosurgeon. In 2018, he became the chair of the department of neurological surgery at UC Davis Health. He is married to business executive Meg Whitman. He is a direct descendant of Revolutionary War General and North Carolina State Senator Griffith Rutherford (1721–1805).

The University of Miami Division of Surgical Neurooncology is the neurological surgery center at the University of Miami's Leonard M. Miller School of Medicine and one of the largest and most comprehensive programs for brain tumor treatment in the United States. It is located in Miami.

<span class="mw-page-title-main">Barrow Neurological Institute</span> Hospital in Arizona, United States

Barrow Neurological Institute is the world's largest neurological disease treatment and research institution, and is consistently ranked as one of the best neurosurgical training centers in the United States. Founded in 1962, the main campus is located at 350 W. Thomas Road, Phoenix, Arizona.

<span class="mw-page-title-main">Aaron Cohen-Gadol</span> American neurosurgeon

Aaron A. Cohen-Gadol is a professor of neurological surgery in the department of neurosurgery at Indiana University School of Medicine and a neurosurgeon at Indiana University Health specializing in the surgical treatment of complex brain tumors, vascular malformations, cavernous malformations, etc. He performs removal of brain tumors via minimally invasive endoscopic techniques, which use the nasal pathways instead of opening the skull.

David S. Baskin is a neurosurgeon who currently works at Houston Methodist Hospital as the Vice Chairman of the Department of Neurosurgery, the Director of the Residency Training program, and the Director of the Kenneth R. Peak Brain & Pituitary Tumor Center, and is also a professor of neurosurgery at Weill Cornell Medical College.

Isabelle M. Germano is a neurosurgeon and a tenured professor of neurosurgery, neurology, and oncology at the Icahn School of Medicine at Mount Sinai Hospital. She is a Fellow of the American College of Surgeons and the American Association of Neurological Surgeons. She is also an author. Germano has worked in image-guided brain and spine surgery.

John Howard Sampson, M.D., Ph.D, M.B.A, M.H.S.c, is the former chief of the department of neurosurgery at Duke University where he serves as a professor of surgery, biomedical engineering, immunology, and pathology.

Robert Wheeler Rand, Ph.D., J.D., M.D., was an American neurosurgeon, inventor, and Professor of Neurosurgery in the Department of Neurosurgery at the University of California Los Angeles (UCLA) from 1953 to 1989.

Viviane Tabar is an American neurosurgeon, the Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center in New York since 2017.

Sheila K. Singh MD, PhD, FRCSC is a chief pediatric neurosurgeon at McMaster Children's Hospital in Ontario, Canada. She is also Professor of Surgery and Biochemistry, the Division Head of Neurosurgery at Hamilton Health Sciences, the Research Director for McMaster's Division of Neurosurgery, and a scientist/principal investigator appointed to the Stem Cell and Cancer Research Institute at McMaster University.

Peter Edward Fecci is an American neurosurgeon, professor and researcher. He is an Associate Professor of Neurosurgery, Pathology and Immunology at Duke University School of Medicine. He also serves as Director of the Duke Center for Brain and Spine Metastasis, Director of the Brain Tumor Immunotherapy Program, Residency Program Director, and Associate Deputy Director of the Preston Robert Tisch Brain Tumor Center at Duke.

Donald M. O'Rourke is an American neurosurgeon and the John Templeton, Jr., MD Professor of Neurosurgery at the Perelman School of Medicine at the University of Pennsylvania. He graduated from Harvard University with an A.B. in Biochemistry and Molecular Biology in 1983, and attended medical school at the University of Pennsylvania where he also completed neurosurgical residency training. He established the institution's human brain tumor tissue bank in 2001. An elected member of the American Academy of Neurological Surgery, his research at the Translational Center of Excellence in the Abramson Cancer Center focuses on Glioblastoma Multiforme, especially the design and investigation of Chimeric Antigen Receptor immune therapies.

Nelson M. Oyesiku is a Nigerian-born professor of neurosurgery and Endocrinology. Currently, he is the chair of the department of Neurological Surgery and Professor of Medicine (Endocrinology) at the University of North Carolina, Chapel Hill, USA. Previously, he served as the director of the Inaugural Daniel Louis Barrow Chair in Neurosurgery, and Vice-Chairman, Department of Neurological Surgery, and Director of the Neurosurgical Residency Program at the Emory University School of Medicine. He was also the Director of Laboratory and Molecular Neurosurgery and Biotechnology at Emory University School of Medicine.

<span class="mw-page-title-main">Duane Mitchell</span> American physician and research scientist

Duane A. Mitchell is an American physician-scientist and university professor. He is currently employed at the University of Florida College of Medicine, in Gainesville, Florida as the Assistant Vice President for Research, Associate Dean for Translational Science and Clinical Research, and Director of the University of Florida (UF) Clinical and Translational Science Institute. He is the Phyllis Kottler Friedman Professor in the Lillian S. Wells Department of Neurosurgery. and Co-Director of the Preston A. Wells, Jr. Center for Brain Tumor Therapy. Mitchell is also the founder, President, and Chairman of iOncologi, Inc., a biotechnology company in Gainesville, FL specializing in immuno-oncology.

<span class="mw-page-title-main">Epitopoietic Research Corporation</span> Belgian pharmaceutical company developing brain cancer treatments

Epitopoietic Research Corporation (ERC) is a Belgian Pharmaceutical company developing ERC1671, which specialise in treatment for Glioblastoma multiforme which is the most aggressive form of brain cancer. In 2019, ERC became the first pharmaceutical company to provide treatment under the US Federal Right-to-try law.

Maria G. Castro is the R. C. Schneider Collegiate Professor of Neurosurgery and a Professor of Cell and Developmental Biology at the University of Michigan Medical School. Her research focuses on cancer immunology and gliomas.

References

  1. 1 2 3 4 "Linda M. Liau, MD, PhD, MBA, FAANS". The Society of Neurological Surgeons. October 9, 2019. Retrieved May 13, 2020.
  2. ↑ ""I Love What I Do": Internationally Renowned Brain Surgeon Dr. Linda Liau". Spectrum News. April 8, 2019. Retrieved May 13, 2020.
  3. 1 2 Wheeler, Mark (2009). "Dr. Linda Liau: Fighting to Beat Brain Cancer". UCLA Medical Magazine. Retrieved May 13, 2020.
  4. 1 2 3 4 Schmidt, Elaine (October 15, 2018). "UCLA neurosurgeon named to National Academy of Medicine". UCLA . Retrieved May 13, 2020.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.